To evaluate the safety and efficacy of BLU-222 therapy in patients with advanced solid tumors.
Thank you for your interest, but this study will start enrolling soon.
North Carolina (Statewide)
Yara Abdou
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Breast)
23-1605
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
